The method of minimization for allocation to clinical trials: A review

Controlled Clinical Trials

Volumn 23, Issue 6, 2002, Pages 662-674

  Scott, Neil W ^a   McPherson, Gladys C ^b   Ramsay, Craig R ^b   Campbell, Marion K ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Clinical trials; Minimization; Randomization; Systematic review

Indexed keywords

ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; PREDICTION; PROGNOSIS; RANDOMIZATION; SAMPLE SIZE; SIMULATION;

CLINICAL TRIALS; HUMANS; RANDOM ALLOCATION; RESEARCH DESIGN;

EID: 0036916803     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(02)00242-8     Document Type: Article

References (47)

1. Pocock S.J. Allocation of patients to treatment in clinical trials. Biometrics. 35:1979;183-197.
2. Taves D.R. Minimization. a new method of assigning patients to treatment and control groups Clin Pharmacol Ther. 15:1974;443-453.
3. Pocock S.J., Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 31:1975;103-115.
4. Freedman L.S., White S.J. On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics. 32:1976;691-694.
5. Begg C.B., Iglewicz B. A treatment allocation procedure for sequential clinical trials. Biometrics. 36:1980;81-90.
6. Atkinson A.C. Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrics. 69:1982;61-67.
7. Smith R.L. Sequential treatment allocation using biased coin designs. J R Statist Soc B. 46:1984;519-543.
8. Klotz J.H. Maximum entropy constrained balance randomization for clinical trials. Biometrics. 34:1978;283-287.
9. Titterington D.M. On constrained balance randomization for clinical trials. Biometrics. 39:1983;1083-1086.
10. Begg C.B., Kalish L.A. Treatment allocation for nonlinear models in clinical trials. the logistic model Biometrics. 40:1984;409-420.
11. Kalish L.A., Harrington D.P. Efficiency of balanced treatment allocation for survival analysis. Biometrics. 44:1988;815-821.
12. Signorini D.F., Leung O., Simes R.J., Beller E., Gebski V.J. Dynamic balanced randomization for clinical trials. Stat Med. 12:1993;2343-2350.
13. Brown BW. Statistical Controversies in the Design of Clinical Trials. Technical Report No. 37. 1978. Division of Biostatistics, Stanford University, Stanford, California.
14. Day S. Commentary. treatment allocation by the method of minimisation BMJ. 319:1999;947-948.
15. Pocock S.J., Lagakos S.W. Practical experience of randomization in cancer trials. an international survey Br J Cancer. 46:1982;368-375.
16. Kalish L.A., Begg C.B. Treatment allocation methods in clinical trials. a review Stat Med. 4:1985;129-144.
17. Peto R., Pike M.C., Armitage P.et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 34:1976;585-612.
18. Simon R. Restricted randomization designs in clinical trials. Biometrics. 35:1979;503-512.
19. Brown B.W. Designing for cancer clinical trials. selection of prognostic factors Cancer Treatment Reports. 64:1980;499-502.
20. Halpern J., Brown B.W. Sequential treatment allocation procedures in clinical trials - with particular attention to the analysis of results for the biased coin design. Stat Med. 5:1986;211-229.
21. Watson H.R., Pearce A.C. Treatment allocation in clinical trials. randomisation and minimisation compared in three test cases Pharmaceutical Medicine. 4:1990;207-212.
22. Zielhuis G.A., Straatman H., Van 'T Hof-Grootenboer A.E.et al. The choice of a balanced allocation method for a clinical trial in otitis media with effusion. Stat Med. 9:1990;237-246.
23. Rovers M.M., Straatman H., Zielhuis G.A., Ingels K., van der Wilt G.-J. Using a balancing procedure in multicenter clinical trials. simulation of patient allocation based on a trial of ventilation tubes for otitis media with effusion in infants Int J Technol Assess Health Care. 16:2000;276-280.
24. Campbell M.K., McPherson G. Simple randomisation or minimisation. the impact of trial size Control Clin Trials. 22:2001;87S.
25. Therneau T.M. How many stratification factors are "too many" to use in a randomization plan? Control Clin Trials. 14:1993;98-108.
26. Atkinson A.C. Optimum biased-coin designs for sequential treatment allocation with covariate information. Stat Med. 18:1999;1741-1752.
27. Atkinson A.C. The comparison of designs for sequential clinical trials with covariate information. J R Statist Soc A. 165:2002;349-373.
28. White S.J., Freedman L.S. Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer. 37:1978;849-857.
29. Lachin J.M., Matts J.P., Wei L.J. Randomization in clinical trials. conclusions and recommendations Control Clin Trials. 9:1988;365-374.
30. Green H., McEntegart D.J., Byrom B., Ghani S., Shepherd S. Minimization in crossover trials with non-prognostic strata. theory and practical application J Clin Pharm Ther. 26:2001;121-128.
31. Buyse M. Centralized treatment allocation in comparative clinical trials. Applied Clinical Trials. 9:2000;32-37.
32. Forsythe AB, Stitt FW. Randomization or Minimization in the Treatment Assignment of Patient Trials: Validity and Power of Tests. Technical Report No. 28. 1977. Health Sciences Computing Facility, University of California, Los Angeles.
33. Birkett N.J. Adaptive allocation in randomized controlled trials. Control Clin Trials. 6:1985;146-155.
34. Kalish L.A., Begg C.B. The impact of treatment allocation procedures on nominal significance levels and bias. Control Clin Trials. 8:1987;121-135.
35. Tu D., Shalay K., Pater J. Adjustments of treatment effect for covariates in clinical trials. statistical and regulatory issues Drug Inf J. 34:2000;511-523.
36. Senn S. A personal view of some controversies in allocating treatment to patients in clinical trials. Stat Med. 14:1995;2661-2674.
37. Senn S. Consensus and controversy in pharmaceutical statistics. The Statistician. 49:2000;135-176.
38. Vaughan Reed J., Wickham E.A. Practical experience of minimisation in clinical trials. Pharmaceutical Medicine. 3:1988;349-359.
39. Treasure T., MacRae K.D. Minimisation. the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does BMJ. 317:1998;362-363.
40. Comparative Obstetric Mobile Epidural Trial (COMET) Study Group UK Effect on low-dose mobile versus traditional epidural techniques on mode of delivery. a randomised controlled trial Lancet. 358:2001;19-23.
41. McPherson G., Campbell M.K., Grant A. Minimisation. the platinum standard for trials? Control Clin Trials. 23:2002;66S.
42. Hamilton S.A. Dynamically allocating treatment when the cost of goods is high and drug supply is limited. Control Clin Trials. 21:2000;44-53.
43. Altman D.G., Doré C.J. Randomisation and baseline comparisons in clinical trials. Lancet. 335:1990;149-153.
44. Ratain J.S., Hochberg M.C. Clinical trials. a guide to understanding methodology and interpreting results Arthritis Rheum. 33:1990;131-139.
45. Kernan W.N., Viscoli C.M., Makuch R.W., Brass L.M., Horwitz R.I. Stratified randomization for clinical trials. J Clin Epidemiol. 52:1999;19-26.
46. Lewis J.A. Statistical principles for clinical trials (ICH E9). an introductory note on an international guideline Stat Med. 18:1999;1903-1942.
47. Steptoe A., Doherty S., Rink E.et al. Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease. randomised trial BMJ. 319:1999;943-948.